France· FR:67059059
CONEBILOX 5 mg/25 mg, comprimé pelliculé
A medicinal product containing hydrochlorothiazide + chlorhydrate de nébivolol, registered in France by MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- HYDROCHLOROTHIAZIDE + CHLORHYDRATE DE NÉBIVOLOL
- Manufacturer
- MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cip133400939397177plaquette(s) polypropylène polycyclooléfine aluminium de 30 comprimé(s)EUR 8.08
- cip133400939397528plaquette(s) polypropylène polycyclooléfine aluminium de 90 comprimé(s)EUR 22.94
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Hydrochlorothiazide + chlorhydrate de nébivolol in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- ItalyALONEBMENARINI INTERNAT. O.L.S.A
- CzechiaNEBILET PLUS HMenarini International Operations Luxembourg S.A., Luxembourg
- SpainLOBIVON PLUS 5 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULAMenarini International Operations Luxembourg S.A.
- SwitzerlandNebilet plus 5/12,5 mg, FilmtablettenA. Menarini GmbH
- FinlandHypoloc CompMenarini International Operations Luxembourg S.A.
- GermanyNebivolol Comp. AbzRatiopharm Gmbh
- PolandNebilet HCTDelfarma Sp. z o.o.
- IrelandNebilet Plus 5 mg/12.5 mg film-coated tabletsMenarini International Operations Luxembourg S.A.
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Nomexor Plus Hct
- Belgium · Nebivolol/Hct Eg, Nobiretic
- Bulgaria · Кардиостад Плюс, Небилет Плюс
- Cyprus · Lobivon-Plus
- Czechia · Nebilet Plus H
- Germany · Nebivolol Comp. Abz, Nebivolol Comp. Ratiopharm
- Denmark · Hypoloc Comp
- Estonia · Nebilet Plus
- Spain · Lobivon Plus, Silostar Plus
- Finland · Hypoloc Comp
- Greece · Hypoloc-Plus, Lobivon-Plus
- Croatia · Nebilet Plus
- Hungary · Nebilet Plus
- Ireland · Nebilet Plus
- Italy · Aloneb, Lobidiur
- Lithuania · Nebilet Plus
- Luxembourg · Nobiretic
- Latvia · Nebilet Plus
- Malta · Nebilet Plus
- Netherlands · Hyporetic, Lobiretic
- Poland · Nebilet Hct
- Portugal · Nebilet Hct
- Romania · Co-Nebilet
- Slovenia · Co-Nebilet
- Slovakia · Nebilet Hctz
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c8ba2198-633e-4537-aadf-57bd7abcc72f GET /v1/drugs/c8ba2198-633e-4537-aadf-57bd7abcc72f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67059059",
"date_amm": "2009-05-27",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "HYDROCHLOROTHIAZIDE + CHLORHYDRATE DE NÉBIVOLOL",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about hydrochlorothiazide + chlorhydrate de nébivolol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.